Lenvat 10Mg Capsule

About Lenvat 10Mg Capsule

Lenvat 10mg Capsule contains Lenvatinib, a targeted anticancer medication belonging to the tyrosine kinase inhibitor (TKI) class. It is primarily used to treat progressive or advanced thyroid cancer that no longer responds to radioactive iodine therapy and is also prescribed for certain patients with unresectable hepatocellular carcinoma (liver cancer) who have not received prior treatment and are not candidates for surgery. Lenvatinib works by blocking specific proteins involved in tumor growth and blood vessel formation, helping to slow cancer progression. Advanced thyroid cancer, including anaplastic thyroid carcinoma, is more common in older adults and may cause symptoms such as a rapidly enlarging thyroid gland and persistent hoarseness. Liver cancer often develops in individuals with chronic liver diseases such as cirrhosis or hepatitis B infection. Patients with a known allergy to Lenvatinib or any of the capsules ingredients should avoid using this medication. Before starting treatment, it is important to inform healthcare providers about any existing medical conditions and medications being taken. Patients should also notify their dentist or oral surgeon if they are using Lenvat 10mg Capsule, as the medication may delay wound healing and increase the risk of bleeding during or after dental and surgical procedures. Regular monitoring throughout treatment helps ensure its safety and effectiveness.